Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases.
Glen Stewart HazlewoodInes ColmegnaCarol A HitchonPaul R FortinSasha BernatskyAnn Elaine ClarkeDianne MosherTodd WilsonMegan ThomasClaire E H BarberMark HarrisonNick BansbackLaurie ProulxDawn P RichardsGilaad G KaplanPublished in: The Journal of rheumatology (2023)
Patients perceived the benefits of COVID-19 vaccination to outweigh rare serious risks and disease flare. This supports COVID-19 vaccine strategies that maximize effectiveness, while recognizing the heterogeneity in preferences that exists.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- newly diagnosed
- respiratory syndrome coronavirus
- physical activity
- peritoneal dialysis
- depressive symptoms
- mental health
- prognostic factors
- oxidative stress
- single cell
- decision making
- patient reported outcomes
- drug induced